Finance

Beta
Lists
KLRS:NASDAQ
Kalaris Therapeutics Inc
$5.27
+1.74%
(+0.090) 1D
May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRS...
Open
$5.21
High
$5.38
Low
$5.10
Mkt. cap
125.39M
Avg. vol.
90.94K
Volume
145.03K
52-wk high
$11.88
52-wk low
$2.14
EPS
-$2.21
Beta
0.15
Shares outstanding
23.79M
No. of employees
20
Open
$5.21
High
$5.38
Low
$5.10
Mkt. cap
125.39M
Avg. vol.
90.94K
Volume
145.03K
52-wk high
$11.88
52-wk low
$2.14
EPS
-$2.21
Beta
0.15
Shares outstanding
23.79M
No. of employees
20
News stories
From sources across the web
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitekalaristx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.44M
9.13M
7.16M
7.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.82M
3.62M
3.64M
4.26M
Operating expense
12.26M
12.74M
10.80M
11.83M
Total operating expenses
12.26M
12.74M
10.80M
11.83M
Operating income
-12.26M
-12.74M
-10.80M
-11.83M
Other non operating income
906.00K
847.00K
803.00K
977.00K
EBT including unusual items
-11.35M
-11.89M
-10.00M
-10.86M
EBT excluding unusual items
-11.35M
-11.89M
-10.00M
-10.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.35M
-11.89M
-10.00M
-10.86M
Net profit margin
-
-
-
-
Earnings per share
-0.61
-0.64
-0.44
-0.46
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-12.74M
-10.79M
-11.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer